RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today that Brian Quigley, CEO, will give a corporate presentation at Gilmartin Group’s inaugural virtual Spring Private Company Showcase. The company will present on Tuesday, April 18, 2023, at 4:00pm ET.
To attend the presentation, please register using this link.
About Qnovia, Inc.
Qnovia, Inc., formerly Respira Technologies, Inc., is a pharma company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company’s drug delivery platform is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient. Qnovia sees significant opportunity to utilize its drug delivery technologies to improve the treatment of asthma, COPD, vaccine delivery, pain management, and several generic as well as select investigational new drugs. The company was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies. The company can be found at www.qnovia.com.
Contacts
Investor Relations:
Kiki Patel, PharmD
Gilmartin Group, Principal
[email protected]
Media Relations:
Richard Laermer
CEO
RLM Public Relations
212-741-5106 X 216
[email protected]
